ChiCTR-TRC-14004478
正在进行
/
/
/
2014-04-10
/
/
Elective surgery with potential massive blood loss requiring blood transfusion
圍手術期輸血指征評分(Peri-Operative Transfusion Trigger Score, POTTS)安全性與有效性的多中心,隨機,對照臨床研究
圍手術期輸血指征評分(Peri-Operative Transfusion Trigger Score, POTTS)安全性與有效性的多中心,隨機,對照臨床研究
圍手術期輸血指征評分(Peri-Operative Transfusion Trigger Score, POTTS)安全性與有效性
随机平行对照
其它
Randomized
pen label
Prince of Wales Hospital, Shatin, Hong Kong
/
20
/
2014-02-20
1990-01-01
/
1. Age older than 14 weeks old; 2. Live in an area of altitude shorter than 2500 m most of the time; 3. Estimated intraoperative blood loss more than 1000ml, or more than 20% of total blood volume.;
登录查看1. Emergency surgery; 2. Patients with physical status of ASA class V or above; 3. Patients with known severe haematological disorders; 4. Patients with known haemaglobinopathy; 5. Acute hypervolemic haemodilution is planned; 6. Patients with known metastatic cancer or more than one neoplasm concurrently; 7. Other conditions that may preclude the patients from the study, such as language barrier, psychiatric disorders, unable to attend research center for follow up; 8. Patients who enrolled to another research study or are taking experimental medication in last 3 months prior to this study; 9. Not suitable for the study, after assessment by the investigators.;
登录查看Prince of Wales Hospital, Shatin, Hong Kong
/
diabetes 埃诺格鲁肽 SLIMMER
医药笔记2025-06-22
遗传性血管性水肿 III期 BD项目
美柏资本2025-06-22
ADA GIPR PCSK9
信达生物2025-06-22
diabetes 埃诺格鲁肽 内分泌学
先为达生物2025-06-22
PDL1 三阴性乳腺癌 atezolizumab
BioArtMED2025-06-21
EGFR 结直肠癌 JMT101
石药集团2025-06-21
糖尿病 GLP-1/GIP
恒瑞医药2025-06-21
肥胖 Wegovy
一度医药2025-06-21